How Will the Market React to Viveve Medical Inc (VIVE) Stock Getting a Bearish Rating

Tuesday, January 24, 2023 03:45 PM | InvestorsObserver Analysts

Mentioned in this article

How Will the Market React to Viveve Medical Inc (VIVE) Stock Getting a Bearish Rating

Overall market sentiment has been down on Viveve Medical Inc (VIVE) stock lately. VIVE receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Viveve Medical Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on VIVE!

See Full VIVE Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With VIVE Stock Today?

Viveve Medical Inc (VIVE) stock is flat -1.77% while the S&P 500 has fallen -0.11% as of 2:44 PM on Tuesday, Jan 24. VIVE is flat $0.00 from the previous closing price of $0.11 on volume of 465,586 shares. Over the past year the S&P 500 has fallen -8.95% while VIVE has fallen -88.30%. VIVE lost -$2.65 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Viveve Medical Inc click here.

More About Viveve Medical Inc

Viveve Medical Inc designs, develops, manufactures and markets a platform medical technology. Its Cryogen-cooled Monopolar Radiofrequency technology is delivered through a radiofrequency generator, handpiece and treatment tip, called the Viveve System. The Viveve System is for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The Viveve System is indicated for use and being marketed for use in general surgical procedures for electrocoagulation and hemostasis in the United States. It has a business presence in the US, Asia Pacific, Canada, Europe and Middle East and Latin America. Click Here to get the full Stock Report for Viveve Medical Inc stock.